Icos Capital is an independent growth capital investment firm that invests in European cleantech companies with leading technology propositions in the growth and expansion phase. The company’s combination of entrepreneurial experience, its growth capital, investment track record, and extensive relationships with international industry professionals has established the firm as a leading strategic partner in the cleantech industry.
Nedermaas Ventures is a regional venture capital fund and a subsidiary entity of the Limburg Development and Investment Company, LIOF. The fund focuses on seed investment opportunities across a broad spectrum of technology fields such as life sciences, biotechology, medical devices, agro/food, and chemistry.
Limburg Ventures is a regional venture capital fund, set up by DSM Nederland and the Limburg Development and Investment Company, LIOF. It invests in promising companies (ranging from start-ups to stock listed) having breakthrough potential, setting up at the Chemelot Campus in Geleen or the Biopartner Centre in Maastricht. The focus is on companies, which will benefit from and strengthen the clusters of advanced materials, biomaterials and biomedical devices, chemistry, and life sciences.
Bonolive®, Cordiart®, Olecol®, Watts’up®, Actiful®, Naxus®, MicrobiomeX® and Flavobiotics® are registered trademarks of BioActor B.V.